Recent advances in percutaneous coronary intervention for chronic total occlusion of coronary artery
-
摘要: 冠状动脉慢性完全闭塞(CTO)病变在经皮冠状动脉介入治疗(PCI)患者中非常普遍，其手术难度大，风险高，目前的临床终点获益尚不明确。本文总结了CTO-PCI随机对照临床试验和观察性研究，介绍了近些年最新的PCI器械和管理策略，以期为CTO-PCI提供全新的理论和实践依据。Abstract: Chronic total occlusion(CTO) of the coronary artery is a common occurrence among patients undergoing percutaneous coronary intervention(PCI), a procedure known for its difficulty and associated risks. However, the precise clinical endpoint benefit of CTO-PCI remains unclear. In this review, we aim to provide a comprehensive summary of recent randomized controlled clinical trials(RCTs) and observational studies pertaining to CTO-PCI. Additionally, we introduced the latest PCI devices and management strategies developed in recent years. By consolidating existing evidence and advancements, this review seeks to offer a new theoretical and practical foundation for enhancing CTO-PCI procedures and outcomes.
-
Key words:
- coronary atherosclerosis /
- occlusive disease /
- interventional therapy
-
-
[1] Goyal A, Shahbaz H, Jain H, et al. The impact of chronic total occlusion in non-infarct related arteries on patient outcomes following percutaneous coronary intervention for STEMI superimposed with cardiogenic shock: A pilot systematic review and meta-analysis[J]. Curr Probl Cardiol, 2024, 49(2): 102237. doi: 10.1016/j.cpcardiol.2023.102237
[2] Dąbrowski EJ, Święczkowski M, Dudzik JM, et al. Percutaneous coronary intervention for chronic total occlusion-contemporary approach and future directions[J]. J Clin Med, 2023, 12(11): 3762. doi: 10.3390/jcm12113762
[3] Costa H, Espírito-Santo M, Bispo J, et al. Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus[J]. Rev Port Cardiol, 2024, 43(4): 167-174. doi: 10.1016/j.repc.2023.07.009
[4] Karacsonyi J, Simsek B, Kostantinis S, et al. Abstract 12578: Development and validation of a scoring system for predicting technical failure during percutaneous coronary interventions of chronic total occlusions: the updated PROGRESS-CTO score[J]. Circulation, 2022, 146: A12578.
[5] Simsek B, Kostantinis S, Karacsonyi J, et al. Predicting periprocedural complications in chronic total occlusion percutaneous coronary intervention: the PROGRESS-CTO complication scores[J]. JACC Cardiovasc Interv, 2022, 15(14): 1413-1422. doi: 10.1016/j.jcin.2022.06.007
[6] Szijgyarto Z, Rampat R, Werner GS, et al. Derivation and validation of a chronic total coronary occlusion intervention procedural success score from the 20, 000-patient EuroCTO registry: the EuroCTO (CASTLE) score[J]. JACC Cardiovasc Interv, 2019, 12(4), 335-342. doi: 10.1016/j.jcin.2018.11.020
[7] Brilakis ES, Grantham JA, Rinfret S, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions[J]. JACC Cardiovasc Interv, 2012, 5(4): 367-379. doi: 10.1016/j.jcin.2012.02.006
[8] Harding SA, Wu EB, Lo S, et al. A new algorithm for crossing chronic total occlusions from the Asia Pacific Chronic Total Occlusion Club[J]. JACC Cardiovasc Interv, 2017, 10(21): 2135-2143. doi: 10.1016/j.jcin.2017.06.071
[9] Tanaka H, Tsuchikane E, Muramatsu T, et al. A novel algorithm for treating chronic total coronary artery occlusion[J]. J Am Coll Cardiol, 2019, 74(19): 2392-2404. doi: 10.1016/j.jacc.2019.08.1049
[10] Wu EB, Brilakis ES, Mashayekhi K, et al. Global chronic total occlusion crossing algorithm: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2021, 78(8): 840-853. doi: 10.1016/j.jacc.2021.05.055
[11] Elias J, Van Dongen IM, Râmunddal T, et al. Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction[J]. Heart, 2018, 104(17): 1432-1438. doi: 10.1136/heartjnl-2017-312698
[12] Kawashima H, Takahashi K, Ono M, et al. Mortality 10 years after percutaneous or surgical revascularization in patients with total coronary artery occlusions[J]. J Am Coll Cardiol, 2021, 77(5): 529-540. doi: 10.1016/j.jacc.2020.11.055
[13] Megaly M, Abraham B, Pershad A, et al. Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior bypass surgery[J]. JACC Cardiovasc Interv, 2020, 13(7): 900-902. doi: 10.1016/j.jcin.2019.11.033
[14] Abo-Aly M, Misumida N, Backer N, et al. Percutaneous coronary intervention with drug-eluting stent versus optimal medical therapy for chronic total occlusion: systematic review and meta-analysis[J]. Angiology, 2019, 70(10): 908-915. doi: 10.1177/0003319719858823
[15] Iannaccone M, D'ascenzo F, Piazza F, et al. Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: a meta-analysis of randomized controlled trials and propensity score adjusted studies[J]. Catheter Cardiovasc Interv, 2019, 93(6): E320-E325.
[16] Megaly M, Ali A, Saad M, et al. Outcomes with retrograde versus antegrade chronic total occlusion revascularization[J]. Catheter Cardiovasc Interv, 2020, 96(5): 1037-1043. doi: 10.1002/ccd.28616
[17] Barbarawi M, Kheiri B, Zayed Y, et al. Meta-analysis of percutaneous coronary intervention versus medical therapy in the treatment of coronary chronic total occlusion[J]. Am J Cardiol, 2019, 123(12): 2060-2062. doi: 10.1016/j.amjcard.2019.03.032
[18] Råmunddal T, Holck EN, Karim S, et al. International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia-ISCHEMIA-CTO trial-rationale and design[J]. Am Heart J, 2023, 257: 41-50. doi: 10.1016/j.ahj.2022.11.016
[19] The NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion[EB/OL].
https://clinicaltrials.gov/ct2/show/NCT03392415?cond=CTO&draw=2&rank=87 .[20] A Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention for the Relief of Stable Angina[EB/OL].
https://clinicaltrials.gov/ct2/show/NCT05142215?term=orbita-cto&draw=2&rank=1 .[21] The Nordic Baltic Chronic Total Occlusion (CTO) Arrhythmia Study[EB/OL].
https://clinicaltrials.gov/ct2/show/NCT04542460 .[22] CTO- PCI in Heart Failure Patients[EB/OL].
https://clinicaltrials.gov/ct2/show/NCT05632653?cond=pci+cto&draw=3&rank=12 .[23] Kostantinis S, Simsek B, Karacsonyi J, et al. Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-CTO registry[J]. Catheter Cardiovasc Interv, 2022, 100(4): 512-519. doi: 10.1002/ccd.30354
[24] Graham JJ, Bagai A, Wijeysundera H, et al. Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-the Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trial[J]. Catheter Cardiovasc Interv, 2022, 99(4): 1065-1073. doi: 10.1002/ccd.30101
[25] Wilgenhof A, Vescovo GM, Bezzeccheri A, et al. Minimalistic hybrid approach for the percutaneous treatment of chronic coronary total occlusions: an in-depth analysis of the whole algorithm[J]. Catheter Cardiovasc Interv, 2022, 100(4): 502-511. doi: 10.1002/ccd.30352
[26] Poletti E, Ohashi H, Sonck J, et al. Coronary CT-guided minimalistic hybrid approach for percutaneous chronic total occlusion recanalization[J]. JACC Cardiovasc Interv, 2023, 16(9): 1107-1108. doi: 10.1016/j.jcin.2023.03.013
[27] Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on Myocardial Revascularization[J]. Eur Heart J, 2019, 40(2): 87-165. doi: 10.1093/eurheartj/ehy394
[28] Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2022, 79(2): e21-e129. doi: 10.1016/j.jacc.2021.09.006
-
下载:
图(1)
计量
- 文章访问数: 685
- PDF下载数: 84
- 施引文献: 0